TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Swedish PharmaInsights AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,419
|
1,296
|
1,430 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-41
|
148
|
269 |
EBITDA |
-50
|
148
|
269 |
Total assets |
980
|
941
|
882 |
Current assets |
980
|
941
|
882 |
Current liabilities |
354
|
273
|
310 |
Equity capital |
626
|
668
|
572 |
- share capital |
5
|
4
|
5 |
Employees (average) |
4
|
3
|
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.9%
|
71.0%
|
64.9% |
Turnover per employee |
355
|
432
|
715 |
Profit as a percentage of turnover |
-2.9%
|
11.4%
|
18.8% |
Return on assets (ROA) |
-4.2%
|
15.7%
|
30.5% |
Current ratio |
276.8%
|
344.7%
|
284.5% |
Return on equity (ROE) |
-6.5%
|
22.2%
|
47.0% |
Change turnover |
119
|
-18
|
151 |
Change turnover % |
9%
|
-1%
|
12% |
Chg. No. of employees |
1
![]() |
1
|
0 |
Chg. No. of employees % |
33%
|
50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.